Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BTX-1188 |
Synonyms | |
Therapy Description |
BTX-1188 is a GSPT1 and IKZF1/3 degrader, which inhibits Myc and potentially induces apoptosis and inhibits tumor growth (J Clinl Oncol 40, no. 16_suppl (June 01, 2022) 7025). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BTX-1188 | BTX 1188|BTX1188 | BTX-1188 is a GSPT1 and IKZF1/3 degrader, which inhibits Myc and potentially induces apoptosis and inhibits tumor growth (J Clinl Oncol 40, no. 16_suppl (June 01, 2022) 7025). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05144334 | Phase I | BTX-1188 | A Study of BTX-1188 in Subjects With Advanced Malignancies | Terminated | USA | 0 |